3
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Polycystic Ovary Syndrome
18
Carcinoma, Non-Small-Cell Lung
14
Colorectal Neoplasms
11
Lung Neoplasms
9
Recurrence
7
Neoplasm Metastasis
5
Colonic Neoplasms
5
Breast Neoplasms
5
Rectal Neoplasms
4
Ovarian Neoplasms
4
Lymphoma, T-Cell, Peripheral
4
Infertility
4
Neoplasms
3
Lymphoma, T-Cell
3
Uterine Cervical Neoplasms
2
Urinary Bladder Neoplasms
2
Sezary Syndrome
2
Papillomavirus Infections
2
Mycosis Fungoides
2
Meningeal Carcinomatosis
2
Lymphoma, T-Cell, Cutaneous
2
Lymphoma, B-Cell
2
Lymphoma
2
Insulin Resistance
2
Infertility, Female
2
Hyperandrogenism
2
Head and Neck Neoplasms
2
Diabetes, Gestational
2
Carcinoma, Transitional Cell
2
Atypical Squamous Cells of the Cervix
2
Interventions
tofacitinib
7
Etanercept
6
Methotrexate
3
Adalimumab
3
secukinumab
2
Nivolumab
2
sotrastaurin
1
sodium luminolate
1
ixekizumab
1
deucravacitinib
1
calcipotriene
1
cabozantinib
1
baricitinib
1
apremilast
1
abrocitinib
1
Vitamin D
1
Vaccines
1
Specimen Handling
1
Saline Solution
1
Platinum Compounds
1
Ipilimumab
1
Herpes Zoster Vaccine
1
Folic Acid
1
Fish Oils
1
Fatty Acids, Omega-3
1
Exercise
1
Eicosapentaenoic Acid
1
Docosahexaenoic Acids
1
Cholecalciferol
1
CTLA-4 Antigen
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Psoriasis
×
Folic Acid
×
Clear all
NCT00932113
2017-08-31
MOA
Tufts Medical Center
Phase 4
Completed
33 enrolled
11 charts